EP1712223 - Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 14.01.2011 Database last updated on 31.08.2024 | Most recent event Tooltip | 21.09.2012 | Lapse of the patent in a contracting state New state(s): LU | published on 24.10.2012 [2012/43] | Applicant(s) | For all designated states Green Cross Holdings 227 Gugal-ri, Giheung-eup Yongin-si, Gyeonggi-do, 449-593 / KR | [2006/42] | Inventor(s) | 01 /
Paik, Sang-Hoon 403, Daewon-Villa Ga-dong 111-2, Dunjeon-ri, Pogo 449-812, Yongin-si, Gyeonggi-do / KR | 02 /
Shin, Yong-Nam 101-108 Samcheolli Apt., Hakseong 1-dong 220-795, Wonju-si, Gangwon-do / KR | 03 /
Kim, Jean-Man 101-905 Jinwoo Apt., Sanmga-dong 449-718, Yongin-si, Gyeonggi-do / KR | 04 /
Huh, Jae-Wook 101-201 Hanyang Apt., Gugal-ri, Giheung-eup 449-736, Yongin-si, Gyeonggi-do / KR | 05 /
Lee, Jung-Sik 204-1504 Dongseong 2-cha Apt., Jukjeon 2-dong 449-754, Yongin-si, Gyeonggi-do / KR | 06 /
Kwon, Ki-Sung 914-106 Jugong Apt., Burim-dong 427-804, Gwacheon-si, Gyeonggi-do / KR | 07 /
Chun, Ji-Hyun 313-704 Yanghyeon Sinan Apt., Singal-ri, Giheung- 449-589, Yongin-si, Gyeonggi-do / KR | [2006/42] | Representative(s) | Svingor, Adam, et al Danubia Patent & Law Office LLC Bajcsy-Zsilinszky út 16 1051 Budapest / HU | [N/P] |
Former [2006/42] | Svingor, Adam, et al Danubia Patent & Trademark Attorneys Bajcsy-Zsilinszky ut 16. 1051 Budapest / HU | Application number, filing date | 05102880.1 | 12.04.2005 | [2006/42] | Priority number, date | KR20040047985 | 25.06.2004 Original published format: KR 2004047985 | [2006/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1712223 | Date: | 18.10.2006 | Language: | EN | [2006/42] | Type: | B1 Patent specification | No.: | EP1712223 | Date: | 10.03.2010 | Language: | EN | [2010/10] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 24.11.2005 | Classification | IPC: | A61K9/19, A61K47/18, A61K38/37 | [2006/42] | CPC: |
A61K9/19 (EP,US);
A61K38/16 (KR);
A61K38/37 (EP,US);
A61P7/00 (EP);
A61P7/04 (EP);
C07K14/755 (EP,US);
A61K47/183 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/42] | Title | German: | Pharmazeutische Zusammensetzung mit lyophilisiertem rekombinantem Faktor VIII ohne Albumin als Stabilisator | [2006/42] | English: | Pharmaceutical preparation of recombinant factor VIII lyophilized without albumin as a stabilizer | [2006/42] | French: | Préparation pharmaceutique du facteur VIII recombinant lyophilisé sans albumine comme stabilisateur | [2006/42] | Examination procedure | 07.12.2006 | Examination requested [2007/03] | 28.03.2008 | Despatch of a communication from the examining division (Time limit: M06) | 26.09.2008 | Reply to a communication from the examining division | 21.09.2009 | Communication of intention to grant the patent | 18.01.2010 | Fee for grant paid | 18.01.2010 | Fee for publishing/printing paid | Opposition(s) | 13.12.2010 | No opposition filed within time limit [2011/07] | Fees paid | Renewal fee | 13.03.2007 | Renewal fee patent year 03 | 10.03.2008 | Renewal fee patent year 04 | 26.02.2009 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | BE | 10.03.2010 | CY | 10.03.2010 | EE | 10.03.2010 | FI | 10.03.2010 | LT | 10.03.2010 | RO | 10.03.2010 | SI | 10.03.2010 | SK | 10.03.2010 | IE | 12.04.2010 | LU | 12.04.2010 | MC | 30.04.2010 | BG | 10.06.2010 | GR | 11.06.2010 | IS | 10.07.2010 | PT | 12.07.2010 | [2012/43] |
Former [2011/08] | BE | 10.03.2010 | |
CY | 10.03.2010 | ||
EE | 10.03.2010 | ||
FI | 10.03.2010 | ||
LT | 10.03.2010 | ||
RO | 10.03.2010 | ||
SI | 10.03.2010 | ||
SK | 10.03.2010 | ||
IE | 12.04.2010 | ||
MC | 30.04.2010 | ||
BG | 10.06.2010 | ||
GR | 11.06.2010 | ||
IS | 10.07.2010 | ||
PT | 12.07.2010 | ||
Former [2011/07] | BE | 10.03.2010 | |
CY | 10.03.2010 | ||
EE | 10.03.2010 | ||
FI | 10.03.2010 | ||
LT | 10.03.2010 | ||
RO | 10.03.2010 | ||
SI | 10.03.2010 | ||
SK | 10.03.2010 | ||
IE | 12.04.2010 | ||
MC | 30.04.2010 | ||
BG | 10.06.2010 | ||
GR | 11.06.2010 | ||
IS | 10.07.2010 | ||
Former [2010/52] | BE | 10.03.2010 | |
CY | 10.03.2010 | ||
EE | 10.03.2010 | ||
FI | 10.03.2010 | ||
LT | 10.03.2010 | ||
RO | 10.03.2010 | ||
SI | 10.03.2010 | ||
SK | 10.03.2010 | ||
MC | 30.04.2010 | ||
BG | 10.06.2010 | ||
GR | 11.06.2010 | ||
IS | 10.07.2010 | ||
Former [2010/38] | FI | 10.03.2010 | |
LT | 10.03.2010 | ||
SI | 10.03.2010 | Documents cited: | Search | [A]JPS6122022 ; | [Y]US4297344 (SCHWINN HORST, et al) [Y] 1-8 * column 3, lines 45-50 * * column 3, line 62 - column 4, line 15 * * column 5, lines 44-49 * * column 6, lines 59-62 * * column 7, lines 18,19 * * claims 1-4 *; | [A]WO9322336 (ALPHA THERAPEUTIC CORP [US]) [A] 1-8 * page 4, lines 1-18 * * page 6, lines 26-28 * * page 14, lines 13-22; table 5 ** claims 1-5,30-34 *; | [Y]US5407671 (HEIMBURGER NORBERT [DE], et al) [Y] 1-8 * column 3, lines 8-25,55-57 * * column 4; example 1 *; | [X]WO9910011 (CSL LTD [AU], et al) [X] 1-8 * page 9, lines 18-26 * * page 11, lines 1-21 * * page 14, lines 7-16 * * page 15; table 1 * * claims 1-9 *; | [A]WO2005004901 (LOBORATOIRE FRANCAIS DU FRACTI [FR], et al) [A] 1-8 * page 1, lines 5-28 * * page 6, lines 13-36 * * page 7, lines 1-3 * * page 9, lines 21-34 * * page 11; example 1; table 1 * * claims 1-21 *; | [A] - DATABASE WPI, 0, Derwent World Patents Index, vol. 1986, no. 11, Database accession no. 1986-072296, XP002350603 & JPS6122022 A 19860130 (GREEN CROSS CORP) [A] 1-8 * column A * |